Exploring an novel diagnostic gene of trastuzumab-induced cardiotoxicity based on bioinformatics and machine learning
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Exploring an novel diagnostic gene of trastuzumab-induced cardiotoxicity based on bioinformatics and machine learning ; volume:14 ; number:1 ; day:3 ; month:12 ; year:2024 ; pages:1-13 ; date:12.2024
Scientific reports ; 14, Heft 1 (3.12.2024), 1-13, 12.2024
- Creator
-
Pei, Jixiang
Feng, Luxin
Mu, Qiang
Wang, Qitang
Wu, Ziying
Wang, Zhimei
Liu, Yukun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-81335-9
- URN
-
urn:nbn:de:101:1-2502172222194.943737343159
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pei, Jixiang
- Feng, Luxin
- Mu, Qiang
- Wang, Qitang
- Wu, Ziying
- Wang, Zhimei
- Liu, Yukun
- SpringerLink (Online service)
Other Objects (12)
Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity
Diagnostic biases in translational bioinformatics
Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 Cases
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report
Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways
HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients
The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity
Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)
Predictors of trastuzumab-induced cardiotoxicity among racially and ethnically diverse patients with HER2-positive breast cancer
Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab
Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity
Diagnostic biases in translational bioinformatics
Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 Cases
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report
Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways
HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients
The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity
Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)
Predictors of trastuzumab-induced cardiotoxicity among racially and ethnically diverse patients with HER2-positive breast cancer
Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab
Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity
Diagnostic biases in translational bioinformatics
Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 Cases
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report
Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways
HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients
The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity
Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)
Predictors of trastuzumab-induced cardiotoxicity among racially and ethnically diverse patients with HER2-positive breast cancer